COMPREHENSIVE PREVENTION RESEARCH IN DRUG ABUSE NIH GUIDE, Volume 23, Number 15, April 15, 1994 PA NUMBER: PA-94-056 P.T. 34 Keywords: Drugs/Drug Abuse Disease Prevention+ National Institute on Drug Abuse PURPOSE The purpose of this program announcement is to encourage rigorous scientific study of the efficacy and effectiveness of multiple component substance abuse prevention technologies implemented across several systems including schools, families, peers, and the social environment (workplace and community) to determine their efficacy and effectiveness in preventing the onset of drug use and progression to abuse. Research focused on the prevention of drug use and the prevention of drug abuse is encouraged. Studies should involve the use of randomized controlled clinical trials or well-controlled quasi-experimental research designs. A secondary goal of the proposed research is the development of psychometrically-sound measures, instruments and data collection procedures to assess the process, outcome, and impact of comprehensive prevention strategies. Special attention should be given to culturally-diverse populations and to sub-populations at high-risk of drug use onset and progression. Research should focus on a broad spectrum of drug behaviors, such as the use of tobacco products, marijuana, cocaine/crack, IV drug use, prescription/over-the-counter medications, and polydrug use/abuse. Research is encouraged that focuses on rural and inner-city populations. Finally, health services research that assesses the effectiveness of comprehensive drug preventive care service systems in real world settings is also requested under this program announcement. HEALTHY PEOPLE 2000 The Public Health Service (PHS) is committed to achieving the health promotion and disease prevention objectives of "Healthy People 2000," a PHS-led national activity for setting priority areas. This program announcement, Comprehensive Prevention Research in Drug Abuse, is related to the priority area of alcohol and other drug abuse. Potential applicants may obtain a copy of "Healthy People 2000" (Full Report: Stock No. 017-001-00474-0 or Summary Report: Stock No. 017-001-00473-1) through the Superintendent of Documents, Government Printing Office, Washington, DC 20402-9325 (telephone 202/783-3238). ELIGIBILITY REQUIREMENTS Applications may be submitted by foreign and domestic, for-profit and non-profit organizations, public and private, such as universities, colleges, hospitals, laboratories, units of State or local governments, and eligible agencies of the Federal government. Applicants from minority individuals and women are encouraged. Foreign institutions are not eligible for First Independent Research Support and Transition (FIRST) (R29) Awards. MECHANISM OF SUPPORT Support mechanisms include research project grants (R01), small grants (R03), FIRST awards (R29), program projects (P01), and Investigator-initiated Interactive Research Project (IRPG) grants (NIH PA number PA-93-078). Because the nature and scope of the research proposed in response to this program announcement may vary, it is anticipated that the size of an award will also vary. RESEARCH OBJECTIVES Background Epidemiologic research over the last fifteen years indicates that significant changes in the use of marijuana and cocaine are related to shifts in the perception of the harmful consequences of drug use and abuse and personal and social disapproval of the use of illicit substances. Controlled intervention research indicates that comprehensive drug prevention programs can promote the formulation of anti-drug social norms and thereby prevent the incidence and reduce the prevalence of the use of cigarettes, alcohol, marijuana, and cocaine for adolescents exposed to comprehensive prevention programs in comparison to those youth not receiving these interventions. Such programs include systematic implementation of multiple components such as effective use of the media; drug education and intervention in the schools and workplace; parent education especially during prenatal, infancy, toddler stage, and early adolescence; formation of self-help groups; development of community coalitions to combat drug abuse and drug distribution; and, enactment and enforcement of salient anti-drug policies within schools, the workplace, and communities. The specific objectives of this research program are to determine the efficacy and effectiveness of comprehensive drug prevention programs in two general areas: (1) to measure the short- and long-term effects of comprehensive drug prevention, and (2) to assess the generalizability of these research findings to high-risk populations. Areas of special interest to this program announcement include, but are not limited to: Strengthening the Development of Positive Self-Regulated Health Behaviors Research is needed to apply our knowledge of relevant determinants of drug use to the design and testing of interventions that strengthen the development of positive self-regulated health behaviors. Etiologic research indicates that drug use and abuse involves a number of risk factors relevant to the individual, family, peer group, and social environment and represents only one of a constellation of interrelated problem behaviors to include: delinquency, academic failure and dropping out of school, juvenile depression, running away from home, unwanted pregnancies, suicidal behavior, sexually transmitted diseases to include HIV infection, and drug/alcohol related traffic accidents. Current prevention intervention research suggests that a comprehensive approach to drug abuse prevention offers the best chance of positively effecting this complex problem. The premise of comprehensive drug prevention is that program activities should focus on the individual and his or her interactions with the social environment. Relevant to the individual, research indicates that a promising approach to prevention would be one that promoted self-regulated health behavior. Research is needed to test the effects of preventive strategies for developing and maintaining: (1) behavior skills, such as self-monitoring, goal setting, self-incentives; (2) cognitive structures, such as self-efficacy and intrinsic motivation; (3) perceptions of the harmful consequences of drug use/abuse; (4) awareness of personal and social disapproval of drug use/abuse; and (5) affective/emotive impulse controls. Research is needed to assess how planned interventions focused on these outcomes can strengthen self-regulated health behavior changes and potentially reduce drug use/abuse. However, research indicates that focusing only upon the individual is insufficient given the vital role played by family, neighbors, peers, friends, teachers, and others in the social environment to encourage and reinforce positive health behavior changes, specifically in regard to the onset, use, and abuse of cigarettes, alcohol, marijuana, crack/cocaine and other drugs. Research is needed to assess how social environments can be structured and strengthened to promote positive self-regulated health behavior change. Multiple Component and Comprehensive Prevention Interventions Research is needed to assess multiple component and comprehensive strategies that simultaneously utilize the schools, media, family, peers, social networks, and health policies to both shape and reinforce the process of self-regulated health behavior change. Intervention research indicates that a comprehensive approach to drug abuse prevention that includes multiple program components can prevent the use of cigarettes, alcohol, marijuana, and cocaine by youth exposed to the program in comparison to controls. Research is needed to test a variety of multiple component prevention strategies. For example, the combination of drug prevention media and school/home-based prevention education premised upon social learning theory may equip youth with generalizable assertiveness skills needed to resist peer pressure to use drugs. Research on the use of mass media combined with school-based prevention education programs has been encouraging and indicates that these two components are essential elements of comprehensive drug prevention programming. Media can increase public awareness of drug abuse problems, promote organizational involvement in preventing substance abuse, create public agendas for community action, strengthen drug-free social norms, stimulate interpersonal discussions relevant to prevention of drug problems, and reinforce changes in relevant health behaviors of individuals residing within the community. School and home-based social skills training can provide individuals with the specific behavioral competency to resist and resolve the inter- and intra-personal pressures to use drugs and alcohol. Research suggests that parent education and life skills training can increase family communication, enhance the use of positive family management techniques, and promote social bonding within the family. Research is needed to assess the efficacy of comprehensive drug prevention that includes parent education. In addition, research is needed to assess comprehensive drug prevention that includes components focused upon re-structuring the social influences of the peer group, increasing the social bonding of youth to school, home, workplace, church or neighborhood youth group, and exposure to positive role models provided by caring adult neighborhood volunteers, such as mentoring. Research is needed for a variety of prevention strategies to include: family preservation models, student assistance programs, modification of school environments, and in-home interventions. Community Organization, Empowerment, and Change Research indicates that to be effective, comprehensive drug prevention needs to extend beyond the individual and social networks represented by interactions with family, peers, and significant others in the neighborhood, and include salient changes in community values, norms, sanctions, and actions relevant to preventing drug use/abuse and neighborhood drug distribution activities. Research is needed to design and test drug prevention strategies that involve community organizations and institutions that establish an environment in which durable, positive self-regulated health behavior change can be developed and maintained. Community involvement and commitment to substance abuse prevention has been traditionally a desired goal of public health programs. However, much is yet to be learned concerning the validity of prevention theories prescriptive of community organization and empowerment and the efficacy of community change interventions based upon these theories. Research is needed to develop and test models of community/environmental change that capitalize upon existing community leadership and organizations to deliver effective drug education messages, encourage environmental change, promote drug-free norms, and establish community coalitions to take effective preventive/deterrent actions particularly within high risk neighborhoods. Research is needed to develop and test the most effective techniques for community change that may involve community advisory boards, task forces, parent groups, professional associations, individual community leaders and relevant grass roots entities. Innovative techniques need to be created and assessed to expand and intensify participation in drug prevention by a variety of community groups representing ethnic-minority points of view. Research is needed to assess the efficacy of grass-roots community coalitions that have been formed to rid their neighborhoods of open-air drug markets and crack houses. Prevention research is needed to assess the short-term and long-term effects of community-based drug abuse deterrence on both drug use/abuse and the drug distribution marketplace and the violence that relates to the presence of drugs in communities. Research is needed to assess the efficacy of drug-related policies and legislation to establish drug-free school and community zones and a drug-free workplace. Research indicates that effective enforcement of drug-free policies and legislation can reduce consumption of drugs to include the use of tobacco products in schools, communities, and the workplace and drug use/abuse in the military. Research is needed to determine how drug-free policies and legislation can enhance the effects of more traditional comprehensive drug prevention activities involving schools and families. Health Services Research The intent of health services prevention research is to assess the effectiveness and cost effectiveness of preventive interventions in reducing drug-related problems, such as adverse medical, psychological, or social consequences of drug use. In addition to intervention studies in health care settings, prevention services research may occur in a variety of other settings (e.g., worksites, schools, and local communities) and may focus on financing, organization, management, enforcement, and utilization of prevention services as well as their effectiveness. Research is needed to improve the quality of prevention services, to expand access to prevention services to all populations, particularly minorities, and to lower costs of health care by reducing the extent of drug use and its adverse health and social consequences. Illustrative drug abuse prevention services research areas include: o Qualitative and quantitative assessment of program service delivery at the community, state, regional, or national level; o Outreach research to assess strategies to expand prevention services to under-served populations and geographic areas, such as rural communities and inner cities; and, o Research to integrate drug prevention with other related behavioral and societal disorders such as violence prevention, unwed pregnancy, school drop-outs, and domestic abuse. Prevention Interventions In Rural Communities Research suggests that drug abuse in rural communities is on the increase and requires special attention through the design and testing of prevention programs and policies that best serve the needs of rural America. Prevention intervention research focused upon rural communities is encouraged by this program announcement STUDY POPULATIONS INCLUSION OF WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN SUBJECTS It is the policy of the NIH that women and members of minority groups and their subpopulations must be included in all NIH supported biomedical and behavioral research projects involving human subjects, unless a clear and compelling rationale and justification is provided that inclusion is inappropriate with respect to the health of the subjects or the purpose of the research. This new policy results from the NIH Revitalization Act of 1993 (Section 492B of Public Law 103-43) and supersedes and strengthens the previous policies (Concerning the Inclusion of Women in Study Populations, and Concerning the Inclusion of Minorities in Study Populations) which have been in effect since 1990. The new policy contains some new provisions that are substantially different from the 1990 policies. All investigators proposing research involving human subjects should read the "NIH Guidelines For Inclusion of Women and Minorities as Subjects in Clinical Research", which have been published in the Federal Register of March 9, 1994 (FR 59 11146-11151), and reprinted in the NIH GUIDE FOR GRANTS AND CONTRACTS of March 18, 1994, Volume 23, Number 11. Investigators may obtain copies from these sources or from the program staff or contact person listed below. Program staff may also provide additional relevant information concerning the policy. APPLICATION PROCEDURES Applications are to be submitted on the grant application form PHS 398 (rev. 9/91) and will be accepted at the standard application deadlines indicated in the application kit. Receipt dates for applications for AIDS-related research are found in the PHS 398 instructions. Application kits are available at most institutional offices of sponsored research and may be obtained from the Office of Grants Information, Division of Research Grants, National Institutes of Health, Westwood Building, Room 449, Bethesda, MD 20892, telephone 301/710-0267). The title and number of this program announcement must be typed in Item 2a on the face page of the application. FIRST applications must include at least three sealed letters of reference attached to the face page of the original application. FIRST applications submitted without the required number of reference letters will be considered incomplete and will be returned without review. The completed original application and five legible copies must be sent or delivered to: Division of Research Grants National Institutes of Health Westwood Building, Room 240 Bethesda, MD 20892** Applicants from institutions that have a General Clinical Research Center (GCRC) funded by the NIH National Center for Research Resources may wish to identify the GCRC as a resource for conducting the proposed research. If so, a letter of agreement from either the GCRC program director or principal investigator could be included with the application. REVIEW CONSIDERATIONS Applications will be assigned on the basis of established PHS referral guidelines. Applications will be reviewed for scientific and technical merit by review groups in accordance with the standard NIH peer review procedures. Following scientific-technical review, the applications will receive a second-level of review by the appropriate national advisory council. Small grant (R03) applications do not receive a second-level of review. AWARD CRITERIA Applications will compete for available funds with all other approved applications assigned to the NIDA. The following will be considered in making funding decisions: quality of the proposed project as determined by peer review, program priorities, and availability of funds. INQUIRIES Written and telephone inquiries to clarify any issues or questions from potential applicants are encouraged. Direct inquiries regarding programmatic areas to: William J. Bukoski, Ph.D. Division of Epidemiology and Prevention Research National Institute on Drug Abuse 5600 Fishers Lane Parklawn Building, Suite 9A53 Rockville, MD 20857 Telephone: (301) 443-1514 Direct inquiries regarding fiscal or grant management issues to: Gary Fleming, J.D., M.A. Grants Management Branch National Institute on Drug Abuse Parklawn Building, Room 8A-54 Rockville, MD 20857 Telephone: (301) 443-6710 AUTHORITY AND REGULATIONS This program is described in the Catalog of Federal Domestic Assistance No. 93.279. Awards are made under authorization of Public Health Service Act, Sections 301 (42 USC 241) and administered under PHS grants policies and Federal Regulations at Title 42 CFR Part 52, "Grants for Research Projects," Title 45 CFR parts 74 & 92, "Administration of Grants," and 45 CFR Part 46, "Protection of Human Subjects." Title 42 CFR Part 2 "Confidentiality of Alcohol and Drug Abuse Patient Records" may also be applicable to these awards. This program is not subject to intergovernmental review requirements of Executive Order 12372 or Health Systems Agency review. Sections of the Code of Federal Regulations are available in booklet form from the U.S. Government Printing Office. Awards must be administered in accordance with the PHS Grants Policy Statement (rev. 10/90), which may be available from your office of sponsored research. The Public Health Service strongly encourages all grant recipients to provide a smoke-free workplace and promote the non-use of all tobacco products. This is consistent with the PHS mission to protect and advance the physical and mental health of the American people. .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |